Keyword: Cell Therapy

News

AstraZeneca to Construct New US Cell Therapy Facility

08.02.2024 -

In a move to launch its cell therapy platforms for critical cancer trials in the US, AstraZeneca is investing $300 million in a new facility in Rockville, Maryland. The...

News

AstraZeneca to Buy Cell Therapy Developer Gracell for Up to $1.2 Billion

03.01.2024 -

AstraZeneca has agreed to acquire Gracell Biotechnologies, a Chinese developer of cell therapies for the treatment of cancer and autoimmune diseases, for up to $1.2...

News

AstraZeneca Invests $245 Million in French Biotech Cellectis

02.11.2023 -

Anglo-Swedish drugmaker AstraZeneca entered into a collaboration and investment agreement with Cellectis, a French clinical-stage biotechnology company, to accelerate the...

News

Fluor Completes Bayer’s First Global Cell Therapy Launch Facility

23.10.2023 -

Fluor Corporation announced today that it has completed construction of Bayer’s first global Cell Therapy Launch Facility in Berkeley, California. Completion was...

News

Bayer Opens New Cell Therapy Production Facility in the US

10.10.2023 -

Bayer has opened a new cell therapy production plant in Berkeley, California, USA, for the production of of BlueRock Therapeutics’ bemdaneprocel (BRT-DA01), an...

News

Lonza, Vertex Break Ground on New US Cell Therapy Plant

05.09.2023 -

Last week, Lonza and Vertex Pharmaceuticals broke ground on a new US facility in Portsmouth, New Hampshire, to manufacture cell therapies for diabetes.

News

Cellares Raises $255 Million for Cell Therapy Development Facility

24.08.2023 -

Cellares, a US-based integrated development and manufacturing organization (IDMO), has secured $255 million in Series C funding to establish a cell therapy development...

News

Adaptimmune and TCR2 Agree Merger

13.03.2023 -

Clinical stage biotechs Adaptimmune and TCR2 Therapeutics have agreed to merge, forming what they said would be a “preeminent cell therapy company focused on creating...